Evaluating Specific Plans to Increase Smoking Quit Attempts in Prison

May 1, 2018 updated by: Christopher Armitage, University of Manchester

The Role of Self-Incentives in Smoking Cessation: A Randomised Controlled Trial Within a Local Prison

Tobacco use is the greatest cause of ill health and early mortality, and smoking is the main contributor to around 75,000 deaths a year in England. The aim of the present research is to test the effect of helping people to reward themselves when they have successfully abstained from smoking and the impact this will have on subsequent smoking cessation. Each participant will be randomly allocated to one of four conditions. The trial requires 159 participants to perform an fully powered statistical analysis. The four conditions include: (1) a control condition (asked to form a plan to quit smoking), (2) an implementation intention condition (asked to form a more specific 'if-then' plan), (3) baseline which include: (1) a control condition (asked to form a plan to quit smoking), (2) a volitional help sheet condition (asked to link temptations with appropriate behavioural responses), (3) a weekly self-incentivising condition (asked to reward themselves at the end of each week that they have successfully abstained from smoking), or (4) a monthly self-incentivising condition (asked to reward themselves at the end of each month that they have successfully abstained from smoking). The main outcome measure will be smoking quit status, which will be verified biochemically at the end of the stop smoking programme, and at six-months post quit date.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The research aims to test the role of self-incentivising implementation intentions in smoking cessation among prisoners aged 18 and over, enrolling on a stop smoking programme provided by Livewire within Risley Prison. The effectiveness of self-incentives has been successfully seen previously within health behaviour change, but not within smoking cessation (ongoing randomised controlled trial in alongside community stop smoking services, and local workplaces). This research will build on this by testing the effectiveness of self-incentives in prisoners' stop smoking attempts.

This study is a randomised controlled trial with the between participants factor of condition which has four levels:

1. Control (plan) 2 Self-generated implementation intention (if-then plan) 3. Weekly self-incentivising implementation intention 4. Monthly self-incentivising implementation intention

The within participants' factor will be time which has three levels:

  1. Baseline (T1)
  2. Follow-up (T2) (end of stop smoking programme)
  3. Follow-up (T3) (six months post quit date)

An ethical concern is that participants in the control condition may struggle more to quit smoking as they will not have the additional benefits of being within an experimental condition which uses self-incentives to aid their quit attempt. A control condition is needed to monitor if quitting smoking is due to the use of self-incentives or another behaviour change technique.

The recruitment process will involve the researcher (Emma Brown) administering study packs to the potential participants. The participant information sheet will be read to each participant and time will be provided to ask any questions. If the participant agrees to take part in the research and complete the questionnaire, then this will be completed with the help of the researcher (Emma Brown) if required. Questionnaires will be placed in a sealed envelope and returned to the University of Manchester by the researcher (Emma Brown).

All participants who are able to provide informed consent and are over the age of 18 years old are eligible to take part in the study. Unfortunately, the study does not cater for people who cannot understand English at the present time, although this will be monitored for amendments in future studies. The study will use a paper format as not to exclude those participants who have limited or no access to the internet.

The participant information sheet included within the study pack alongside the questionnaire includes details about the study, costs and benefits of taking part in the study, and the right to consent and withdraw at any point throughout the study. There are no risks involved in taking part in the study. There is a minimal burden in time taken to complete the baseline questionnaire to take no longer than 15 minutes and the further two follow-up questionnaires to take no longer than 10 minutes.

In terms of confidentiality, participants are asked to form a personal identification code to match baseline and follow-up questionnaires once completed.

There are no conflicts of interest. Results will be fed back to all participating services and participants involved in the study, should they indicate for a summary of the results.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cheshire
      • Warrington, Cheshire, United Kingdom, WA3 6BP
        • Risley Prison

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 18 or over
  • Able to understand verbal English
  • Competent to provide informed consent
  • Attending or previously attended the stop smoking services provided

Exclusion Criteria:

  • Not aged 18 or over
  • Not able to understand verbal English
  • Not competent to provide informed consent
  • Not attending or previously attended the stop smoking services provided

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Participants read a brief statement designed to encourage them to quit smoking (we would like you to plan to quit smoking). Participants are then asked to form their plan to quit smoking.
Participants are asked to form plans to quit smoking using various descriptions specified dependent on the arm in which they are randomised.
Active Comparator: Implementation Intention
Participants read a brief statement designed to encourage them to quit smoking (we would like you to plan to quit smoking). Participants are then asked to form a specific 'if-then' plan using an implementation intention basis.
Participants are asked to form plans to quit smoking using various descriptions specified dependent on the arm in which they are randomised.
Experimental: Weekly Self-Incentivising
Participants read a brief statement designed to encourage them to quit smoking (we would like you to plan to quit smoking). Participants are then asked to specify a self-incentive on which they could implement at the end of each week which they have been successful in not smoking.
Participants are asked to form plans to quit smoking using various descriptions specified dependent on the arm in which they are randomised.
Experimental: Monthly Self-Incentivising
Participants read a brief statement designed to encourage them to quit smoking (we would like you to plan to quit smoking). Participants are then asked to specify a self-incentive on which they could implement at the end of each month which they have been successful in not smoking.
Participants are asked to form plans to quit smoking using various descriptions specified dependent on the arm in which they are randomised.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Smoking status
Time Frame: up to 6-months
up to 6-months

Secondary Outcome Measures

Outcome Measure
Time Frame
Amount of cigarettes smoked at both followup time periods
Time Frame: up to 6-months
up to 6-months
Smoking behaviour (habitual)
Time Frame: up to 6-months
up to 6-months
Intentions to stop smoking
Time Frame: up to 6-months
up to 6-months
Self-regulation strategies used
Time Frame: up to 6-months
up to 6-months
Source of motivation to quit smoking
Time Frame: up to 6-months
up to 6-months
Compliance to self-incentivise
Time Frame: up to 6-months
up to 6-months
Frequency of self-incentivisation
Time Frame: up to 6-months
up to 6-months
Self-incentives used
Time Frame: up to 6-months
up to 6-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher J Armitage, University of Manchester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

September 30, 2015

First Submitted That Met QC Criteria

October 1, 2015

First Posted (Estimate)

October 2, 2015

Study Record Updates

Last Update Posted (Actual)

May 4, 2018

Last Update Submitted That Met QC Criteria

May 1, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 15428

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behaviour

Clinical Trials on Self-Incentive

Subscribe